Stay updated with breaking news from Devices Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Falls Church, VA (PRWEB) December 01, 2021 -- Special Pathways for Innovative Devices: A Guide to the FDA’s Breakthrough Device and Safer Technologies
/PRNewswire/ -- Renovia Inc. ("Renovia"), a women-led company that develops digital therapeutics for female pelvic floor disorders, announced today that the...
The MCIT/RN Rule was intended to address concerns that delay or uncertainty around Medicare coverage hampered beneficiary access to innovative technologies.
By Yakir Benzion, United With Israel The Israeli medical device company IceCure received a huge boost after American authorities approved the company’s revolutionary ProSense system for treating cancerous tumors by freezing them, Globes reported Sunday. The U.S. Food and Drug Administration (FDA) gave marketing approval to ProSense as part of the FDA’s Breakthrough Devices Program that fast-tracks new devices to the market. Based in Caesarea, north of Tel Aviv, and with offices in America, IceCure Medical developed a system that uses liquid nitrogen-based technology to freeze tumors so t...
Shoshanna Solomon is The Times of Israel's Startups and Business reporter The technology developed by IceCure Medical Ltd. destroys tumors by freezing them in a minimally invasive procedure with no surgery or hospitalization requirement (Courtesy) IceCure Medical, an Israel-based maker of tumor-freezing technology, said Sunday that it had received notification from the US Food and Drug Administration recognizing its ProSense product as a “breakthrough device” to freeze tumors in a number of medical conditions including breast cancer. The breakthrough devices recognition is given by the F...